Orexo recently launched the digital therapies deprexis and vorvida in the US. Lu Rahman talked to Nikolaj Sørensen, President and CEO about these therapies and the company’s expertise LR: Explain how digital therapies work and the type of conditions they are most suited to treat. NS: Digital therapeutics are evidence-based therapeutic interventions driven by high-quality […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!